Home / Inspections / 1094014

FDA Inspection 1094014 — Cherokee Pharmaceuticals, LLC

Cherokee Pharmaceuticals, LLC — FEI 2510561

The FDA completed an inspection of Cherokee Pharmaceuticals, LLC on May 8, 2019 in Riverside, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 8, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Riverside, PA (United States)

Facility

Other inspections at this facility

  • 1274434 (NAI Wed Jun 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987809 (NAI Wed Sep 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 848039 (NAI Thu Sep 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 635789 (NAI Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources